[{"AccountsPayableCurrent_0_Q3_USD":17564000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-209067000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":114465000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":45366000.0,"RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments_3_Q3_USD":0.0,"ProfitLoss_3_Q3_USD":-143748000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":0.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_3_Q3_USD":0.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":335163000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":330905000.0,"PrepaidInsurance_0_Q3_USD":4558000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":13833000.0,"RoyaltyExpense_3_Q3_USD":0.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":188627000.0,"OtherNonoperatingGainsLosses_3_Q3_USD":-10000.0,"OtherNonoperatingGainsLosses_1_Q3_USD":-5000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":3000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":3000.0,"OtherAssetsNoncurrent_0_Q3_USD":6115000.0,"OtherAssetsCurrent_0_Q3_USD":579000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":660000.0,"OperatingLeasesRentExpenseNet_1_Q3_USD":100000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingIncomeLoss_3_Q3_USD":-143818000.0,"SaleOfStockPricePerShare_0_Q3_USD":8.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":21853000.0,"UnrealizedLossOnSecurities_3_Q3_USD":0.0,"UnrealizedGainOnSecurities_3_Q3_USD":3000.0,"TreasuryStockValue_0_Q3_USD":0.0,"TreasuryStockShares_0_Q3_shares":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":504709000.0,"StockholdersEquity_0_Q3_USD":633213000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.12,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":17460961.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":586814000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":11052000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":586814000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":9.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":14725078.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":232187.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":2.32,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1025630.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":40943000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_Q3_shares":1734101.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":3859139.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":0.0,"ShareBasedCompensation_3_Q3_USD":9908000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":17460961.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":20346771.0,"OperatingIncomeLoss_1_Q3_USD":-60418000.0,"OperatingExpenses_1_Q3_USD":60418000.0,"CommonStockSharesOutstanding_0_Q3_shares":111251660.0,"CommonStockSharesIssued_0_Q3_shares":111251660.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":36417895.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":363281000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":478269000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":478269000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q3_USD":0.0,"AssetsFairValueAdjustment_3_Q3_USD":188053000.0,"AssetsCurrent_0_Q3_USD":680155000.0,"CommonStockValue_0_Q3_USD":5000.0,"Assets_0_Q3_USD":686270000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":21320100.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":9908000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5979000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5979000.0,"AdjustmentForAmortization_3_Q3_USD":188050000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":842272000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":3000.0,"AccruedProfessionalFeesCurrentAndNoncurrent_0_Q3_USD":2239000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":35485000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":35485000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":2575000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":577000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":21320100.0,"OperatingExpenses_3_Q3_USD":143818000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-60372000.0,"ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_0_Q3_USD":0.0,"NonoperatingIncomeExpense_3_Q3_USD":70000.0,"NonoperatingIncomeExpense_1_Q3_USD":43000.0,"NetIncomeLoss_3_Q3_USD":-143748000.0,"NetIncomeLoss_1_Q3_USD":-60375000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-111524000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-188627000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":663432000.0,"MarketableSecurities_0_Q3_USD":188053000.0,"LiabilitiesCurrent_0_Q3_USD":53049000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":686270000.0,"Liabilities_0_Q3_USD":53057000.0,"InvestmentIncomeInterest_3_Q3_USD":80000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-143745000.0,"InvestmentIncomeInterest_1_Q3_USD":48000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":11342000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-6016000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":30122000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":8909000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_3_Q3_USD":-7.06,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q3_USD":-0.98,"GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_3_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":86700000.0,"CostsAndExpensesRelatedParty_3_Q3_USD":2261000.0,"CostsAndExpensesRelatedParty_1_Q3_USD":1826000.0,"InterestReceivable_0_Q3_USD":682000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":61297086.0,"Ticker":"ADGI","CIK":"1832038","name":"ADAGIO THERAPEUTICS, INC.","OfficialName":"Adagio Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"356444312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]